Tech Company Financing Transactions
BostonGene Funding Round
NEC participated in a $50 million Series A funding round for BostonGene. The round was announced on 4/26/2019.
Transaction Overview
Company Name
Announced On
4/26/2019
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
NEC (Osamu Fujikawa)
Proceeds Purpose
The funding will allow BostonGene to accelerate its long-term strategy, enable the expansion of the company's development efforts, advance its collaboration programs, and support the growth of its talented and diverse team.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
95 Sawyer Rd.
Waltham, MA 02453
USA
Waltham, MA 02453
USA
Phone
Website
Email Address
Not Recorded
Overview
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. Our unique solution continuously aggregates the latest cancer research and clinical information from around the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Feinberg
Browse more venture capital transactions:
Prev: 4/26/2019: Tempo Automation venture capital transaction
Next: 4/26/2019: Meru Health venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs